Female hypoactive sexual desire disorder: History and current status

Journal of Sexual Medicine

Volumn 3, Issue 3, 2006, Pages 408-418

  Segraves, Robert ^a   Woodard, Terri ^a  

^a MetroHealth ^*  (United States)

Author keywords

Endocrinologic studies of sexual function; History of sexual dysfunction; Hypoactive sexual desire disorder; Pharmacologic studies in sexual function

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMFEBUTAMONE; ANDROGEN; ANTIDEPRESSANT AGENT; APOMORPHINE; DIETHYLSTILBESTROL; DOPAMINE RECEPTOR STIMULATING AGENT; ESTROGEN; FLIBANSERIN; HORMONE; LASOFOXIFENE; LEVODOPA; METHYLTESTOSTERONE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; OXYTOCIN RECEPTOR ANTAGONIST; PERGOLIDE; PHOSPHODIESTERASE INHIBITOR; PIPERAZINE; PLACEBO; PROSTAGLANDIN E1; QUINELORANE; RECEPTOR BLOCKING AGENT; SEROTONIN UPTAKE INHIBITOR; SILDENAFIL; TESTOSTERONE; TIBOLONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

CLINICAL TRIAL; DATA ANALYSIS; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG INDICATION; DRUG SAFETY; FEMALE; HOT FLUSH; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LIBIDO DISORDER; MEDICAL LITERATURE; MENTAL DISEASE; NONHUMAN; PRACTICE GUIDELINE; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOMETRY; PSYCHOPHARMACOTHERAPY; PUBLICATION; RETROSPECTIVE STUDY; REVIEW; SEXUAL DYSFUNCTION;

EID: 33646007691     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2006.00246.x     Document Type: Article

References (91)

1. Riley A, May K. Sexual desire disorders. In: Gabbord G, ed. Treatments of Psychiatric Disorders, 3rd edn. Washington, DC: American Psychiatric Press; 2001: 1849-72.
2. Fourcroy J. Female sexual dysfunction. Drugs 2003; 63: 1445-57.
3. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 2nd edn. Washington, DC: American Psychiatric Press; 1968.
4. Masters WH, Johnson VE. Human Sexual Inadequacy. Boston, MA: Little Brown; 1970.
5. Lief HI. Inhibited sexual desire. Med Aspects Hum Sex 1977; 7: 94-5.
6. Kaplan HS. Hypoactive sexual desire disorder. J Sex Marital Ther 1977; 3: 3-9.
7. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn. Washington, DC: American Psychiatric Press; 1980.
8. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 3rd edn, text revision. Washington, DC: American Psychiatric Press; 1987.
9. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Press; 1994.
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn, text revision. Washington, DC: American Psychiatric Press; 2000.
11. World Health Organization. ICD-10. International Statistical Classification of Diseases and Related Health Problems, 10th edn. Geneva: World Health Organization; 1992.
12. World Health Organization. ICD-10. Classification of Mental and Behavioral Disorders: Clinical Description and Diagnostic Guidelines. Geneva: World Health Organization; 1993.
13. Basson R, Berman J, Burnett A, Derogatis L, Ferguson D, Fourcroy J, Goldstein I, Graziottin A, Heiman J, Laan E, Leiblum S, Padma-Nathan H, Rosen R, Segraves R, Segraves K, Shabsigh R, Sipski G, Whipple B. Report of the international consensus development conference on female sexual dysfunction. J Sex Marital Ther 2001; 27: 93-4.
14. Basson R, Leiblum S, Brotto L, Derogatis L, Fourcroy J, Fugl-Meyer K, Graziottin A, Heiman JR, Laan E, Meston C, Schover L, van Lankveld J, Schultz WW. Revised definitions of women's sexual dysfunction. J Sex Med 2004; 1: 40-8.
15. Basson R. Female hypoactive sexual desire disorder. In: Balon R, Segraves RT, eds. Handbook of Sexual Dysfunction. New York: Taylor & Francis; 2005: 43-66.
16. Utian W, MacLean D, Symonds T, Somayaji V, Sission M. A methodological study to validate a structured diagnostic method used to diagnose female sexual dysfunction and its subtypes in postmenopausal women. J Sex Marital Ther 2005; 31: 271-83.
17. FDA Guidance Document, Guidance for Industry. Female sexual dysfunction: Clinical development of drug products for treatment. Available at: http://www.fda.gov/cder/guidance/3312dft.htm. 2000. [accessed March 21, 2006].
18. Althof S, Dean J, Derogatis L, Rosen R, Sisson M. Current perspectives on the clinical assessment and diagnosis of female sexual dysfunction and clinical studies of potential therapies. J Sex Med 2005; 2 (suppl 3): 146-53.
19. Althof S, Rosen R, DeRogatis L, Corty E, Quirk F, Symonds T. Outcome measures in female sexual dysfunction clinical trials: Review and recommendations. J Sex Marital Ther 2005; 31: 153-66.
20. Taylor JF, Rosen RC, Leiblum S. Self-report assessment of female sexual function: Psychometric evaluation of the Brief Index for Sexual Functioning for women. Arch Sex Behav 1994; 23: 627-43.
21. Spector IP, Carey M, Steinberg L. The Sexual Desire Inventory. Development, factor structure and evidence of reliability. J Sex Marital Ther 1996; 22: 175-90.
22. Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R, Ferguson D, D'Agostino R. The Female Sexual Function Index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000; 26: 191-208.
23. Keller A, McGarvey E, Clayton A. Reliability and construct validity of the Changes in Sexual Functioning Questionnaire short form (CSFQ-14). J Sex Marital Ther 2006; 32: 43-52.
24. Sills T, Wunderlich G, Pyke R, Segraves R, Leiblum S, Clayton A, Cotton D, Evans K. The Sexual Interest and Desire Inventory - Female (SIDI-F): Item response analysis of data from women diagnosed with hypoactive sexual desire disorder. J Sex Med 2005; 2: 801-18.
25. Kinsey AC, Pomeroy WB, Martin C. Sexual Behavior in the Human Female. Philadelphia, PA: W.B. Saunders; 1953.
26. Paik A, Laumann EO. Prevalence of women's sexual problems in the USA. In: Goldstein I, Meston C, Davis S, Traish A, eds. Women's Sexual Function and Dysfunction. Study, Diagnosis and Treatment. New York: Taylor & Francis; 2006: 23-33.
27. Fugl-Meyer A, Fugl-Meyer K. Prevalence data in Europe. In: Goldstein I, Meston C, Davis S, Traish A, eds. Women's Sexual Function and Dysfunction. Study, Diagnosis and Treatment. New York: Taylor & Francis; 2006: 34-41.
28. Kang J, Laumann E, Glasser D, Paik A. Worldwide prevalence and correlates. In: Goldstein I, Meston C, Davis S, Traish A, eds. Women's Sexual Function and Dysfunction. Study, Diagnosis and Treatment. New York: Taylor & Francis; 2006: 42-51.
29. Johnson SD, Phelps DL, Cottler LB. The association of sexual dysfunction and substance abuse among a community epidemiological sample. Arch Sex Behav 2004; 33: 55-63.
30. Laumann E, Paik A, Rosen RC. Sexual dysfunction in the United States: Prevalence and predictors. JAMA 1999; 281: 537-44.
31. Lewis R, Fugl-Meyer K, Bosch R, Fugl-Meyer A, Laumann E, Lizza E, Martin-Morales A. Epidemiology/risk factors of sexual dysfunction. J Sex Med 2004; 1: 35-9.
32. Hayes R, Dennerstein I. The impact of aging on sexual function and sexual dysfunction in women: A review of population-based studies. J Sex Med 2005; 2: 317-30.
33. Laumann E, Nicolsi A, Glasser D, Paik A, Gingell C, Moreira E, Wang T. Sexual problems among women and men aged 40-80 years: Prevalence and correlates identified in the Global Study of Sexual Attitudes and Behavior. Int J Impot Res 2005; 17: 39-57.
34. Mercer CH, Fenton KA, Johnson AM. Sexual function problems and help seeking behavior in Britain: National probability sample survey. Br Med J 2003; 327: 426-7.
35. Garde K, Lunde I. Female sexual behavior. A study of a random sample of 40-year old women. Maturitas 1989; 2: 225-40.
36. Schwartz MF, Masters WH. Inhibited sexual desire. The Masters and Johnson Institute Treatment Model. In: Leiblum SB, Rosen R, eds. Sexual Desire Disorders. New York: Guilford Press; 1988: 229-242.
37. LoPiccolo L, Friedman JM. Low sexual desire. In: Leiblum SB, Rosen R, eds. Sexual Desire Disorders. New York: Guilford Press; 1988: 107-44.
38. Kaplan HS. The Sexual Desire Disorders. New York: Brunner/Mazel; 1995.
39. Levine S. An essay on the nature of sexual desire. J Sex Marital Ther 1984; 10: 83-96.
40. Scharff D. The Sexual Relationship: An Objects Relations View of Sex and the Family. London: Routledge & Kegan Paul; 1982.
41. Lazarus A. A multimodal perspective on problems of sexual desire. In: Leiblum S, Rosen R, eds. Sexual Desire Disorders. New York: Guilford Press; 1988: 145-67.
42. LoPiccolo J, Friedman J. Broad-spectrum treatment of low sexual desire: Integration of cognitive, behavioral and systemic therapy. In: Leiblum S, Rosen R, eds. Sexual Desire Disorders. New York: Guilford Press; 1988: 107-44.
43. Rosen R, Leiblum S. Current approaches to the evaluation of sexual desire disorders. J Sex Marital Ther 1987; 23: 141-62.
44. McCabe MP. Evaluation of a cognitive behavioral therapy program for people with sexual dysfunction. J Sex Marital Ther 2001; 27: 259-71.
45. Trudel G, Marchand A, Ravart M, Aubin S, Turgeon L, Fortier P. The effect of a cognitive behavioral group treatment program on hypoactive sexual desire in women. Sex Rel Ther 2001; 16: 145-64.
46. Abel S. Androgen therapy in malignant disease of the female genitlia. Am J Obstet Gynec 1945; 49: 327-42.
47. Adair F, Herman J. The use of testosterone propionate in the treatment of advanced carcinoma of the breast. Ann Surg 1946; 123: 1023-35.
48. Greenblatt R, Wilcox E. Hormonal therapy of fibromyomas of the uterus. S Surg 1941; 10: 339-46.
49. Loeser A. subcutaneous implantation of female and male hormones in tablet form in women. Br Med J 1940; 1: 479-82.
50. Groome JR. A local use for testosterone. Lancet 1939; 2: 732.
51. Greenblatt RB, Barfield WE, Garner JF, Calk GL, Harrod JP. Evaluation of an estrogen, androgen, estrogen-androgen combination and a placebo in the treatment of the menopause. J Clin Endocrinol 1950; 10: 1547-58.
52. Sherwin BB, Gelfand MM. Effects of parental administration of estrogen and/or androgen administration on plasma hormone levels and hot flashes in the surgical menopause. Am J Obstet Gynecol 1984; 148: 531-59.
53. Sherwin BB, Gelfand MM. Differential symptom response to parental estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol 1985; 151: 153-60.
54. Sherwin BB, Gelfand MM, Brender W. Androgen enhances sexual motivation in females: A prospective, crossover study of sex steroid administration in the surgical menopause. Psychosom Med 1985; 47: 339-51.
55. Burger HG, Hailes J, Nelson J, Menelaus M. Effect of combined implants of estradiol and testosterone on libido in postmenopausal women. Br Med J 1987; 294: 936-7.
56. Davis S, McCloud P, Strauss B, Burger H. Testosterone enhances estradiol's effects on postmenopausal bone density and sexuality. Maturitas 1995; 21: 227-36.
57. Sarrel P, Dobay B, Wiita B. Estrogen and estrogen-androgen replacement in postmenopausal women dissatisfied with estrogen-only therapy. Sexual behavior and neuroendocrine response. J Reprod Med 1998; 43: 847-56.
58. Barrett-Conner E. Efficacy and safety of estrogen/androgen therapy: Menopausal symptoms, bone and cardiovascular parameters. J Reprod Med 1998; 43: 746-52.
59. Basson R, Schulz W, Binik Y, Brotto L, Eschenbach E, Laan E, Utian W, Wesselmann U, Lankveld Y, Wyatt L, Leiblum S, Althof S, Redmond G. Women's sexual desire and arousal disorders and sexual pain. In: Lue T, Basson R, Rosen R, Giuliano F, Khoury S, Montorsi F, eds. Sexual Medicine. Sexual Dysfunctions in Men and Women. Plymouth: Health Publications; 2004: 853-974.
60. Shifren JL, Braustein G, Simon J. Transdermal testosterone treatment in women with impaired sexual function after oophorectomy. N Engl J Med 2000; 343: 682-8.
61. Bachman G, Bancroft J, Braunstein G. Female androgen insufficiency syndrome: The Princeton consensus statement on definition, classification and assessment. Fertil Steril 2002; 77: 660-5.
62. Davis S, Guay A, Shifren J, Mazer N. Endocrine aspects of female sexual dysfunction. J Sex Med 2004; 1: 82-6.
63. Hatzichristou D, Rosen R, Broderick G, Clayton A, et al. Clinical evaluation and management strategy for sexual dysfunctions in men and women. J Sex Med 2004; 1: 49-57.
64. Basson R, Althof S, Davis S, Fugl-Meyer K, et al. Summary of the recommendations on sexual dysfunctions in women. J Sex Med 2004; 1: 24-34.
65. Utian W, Braunstein G, Buster J, Lucas J, Simon J. Testosterone transdermal patch improved sexual activity and sexual desire in surgically menopausal women: Results from two phase III studies. International society Study Women's Sexual Health, Atlanta, October 28-31, 2004.
66. Buster J, Kingsberg S, Aguirre O, Brown C, Breaux J, Buch A, Rodenberg C, Wekselman K, Casson P. Testosterone patch for low sexual desire in surgically menopausal women: A randomized trial. Obstet Gynecol 2005; 105: 944-52.
67. Jolly E, Kroll R, Shifren J, Wekselman K. Improved sexual function in naturally menopausal women using testosterone transdermal patch. Study Women's Sexual Health, Atlanta, October 28-31, 2004.
68. Roussouw J, Anderson G, Prentice R, La Croix A, Kooperberg C, Stefanick M, Jackson R, Beresford S, Howard B, Johnson K, Kotchen J, Ochere J. Risks and benefits of estrogen plus progestin in healthy postmenopausal women: Principal findings of the Women's Health Initiative randomized controlled trial. JAMA 2002; 288: 321-33.
69. Guay A. Efficacy and pharmacokinetics of topical testosterone gel 605% (Tostrele) in post menopausal women with low androgens and sexual dysfunction. Study Women's Sexual Health, Atlanta, October 28-31, 2004.
70. Lehman L, Zborowski J, Simes S, Simon J. Efficacy and safety of Libigel - A novel testosterone gel for decreased sexual desire. Study Women's Sexual Health, Atlanta, October 28-31, 2004.
71. Davis S, Davison S, Donath S, Bell R. Circulating androgen levels and self-reported sexual function in women. JAMA 2005; 294: 91-6.
72. Tuiten A, Van Honk J, Koppeschaar H, Bernaards C, Thijssen J, Verbaten R. Time course of effects of testosterone administration on sexual arousal in women. Arch Gen Psychiatry 2000; 57: 149-53.
73. Laan E, Van Lunsen R, Everaerd W. The effect of tibilone on vaginal blood flow, sexual desire and arousability in postmenopausal women. Climacteric 2001; 1: 28-41.
74. Gennari L. Lasofoxifene. Curr Opin Investig Drugs 2005; 10: 1067-78.
75. Basson R, McInnes R, Smith M. Efficacy and safety of sildenafil citrate in women with sexual dysfunction associated with female sexual arousal disorder. J Womens Health Gend Based Med 2002; 11: 367-77.
76. Fisher WA, Rosen RC, Eardley I, Sand M, Goldstein I. Sexual experiences of female partners of men with erectile dysfunction; The Female Experience of Men's Attitudes to Life Events and Sexuality (FEMALES) study. J Sex Med 2005; 2: 675-84.
77. Goldstein I, Fisher W, Sand M, Rosen R, Mollen M. Women's sexual function improves when partner's are administrated vardenafil for erectile dysfunction: A prospective randomized, double-blind, placebo-controlled trial. J Sex Med 2005; 2: 819832.
78. Hull E, Muschamp J, Sato S. Dopamine and serotonin: Influences on male sexual behavior. Physiol Behav 2004; 83: 291-307.
79. Segraves RT. Effects of psychotrophic drugs on human erection and ejaculation. Arch Gen Psychiatry 1989; 46: 275-84.
80. Pohanka M. Pergolide mesylate can improve sexual dysfunction in patients with Parkinson's disease; The results of an open, prospective, 6-month follow-up. Eur J Neurol 2004; 11: 483-8.
81. Eardley I, Wright P, MacDonagh R, Hole J, Edwards A. An open label, randomized, crossover study to assess the comparative efficacy and safety of sildeanfil citrate and apomorphine hydrocholoride in men with erectile dysfunction. BJU Int 2004; 93: 1271-5.
82. Perimenis P, Markou S, Gyftopoulis K, Giannitsas K, Athanasopoulos A, Liaksikos E, Barbalias G. Efficacy of apomorphine and sildenafil in men with nonarteriogenic erectile dysfunction. A comparative crossover study. Andrologia 2004; 36: 106-10.
83. Segraves R, Bari M, Segraves K, Spirnak P. Effect of apomorphine on penile tumescence in men with psychogenic impotence. J Urol 1991; 145: 1174-5.
84. Pomerantz S. Dopaminergic influences on male sexual behavior of rhesus monkeys: Effects of dopamine agonists. Pharmacol Biochem Behav 1992; 41: 511-7.
85. Pomerantz S. Quineloraine (LY163502), a D2 dopamine receptor agonist, acts centrally to facilitate penile erections of male rhesus monkeys. Pharmacol Biochem Behav 1991; 39: 123-8.
86. Cameron J. Dopaminergic stimulation of oxytocin concentrations in the plasma of male and female monkeys by apomorphine and a D2 receptor agonist. J Clin Endocrinol Metab 1992; 75: 855-60.
87. Miller W, Pasta D, MacMurray J, Chiu C, Wu H, Comings D. Dopamine receptor genes are associated with age at first sexual intercourse. J Biosoc Sci 1999; 31: 43-54.
88. Segraves RT. Antidepressant-induced sexual dysfunction. J Clin Psychiatry 1998; 59 (suppl 4): 48-54.
89. Segraves RT. Female sexual disorders: Psychiatric aspects. Can J Psychiatry 2002; 47: 419-25.
90. Argiolas A, Melis M, Murgia S, Schioth H. ACTH- and alpha-MSH-induced grooming, stretching, yawning and penile erection in male rats: Site of action in the brain and role of melanocortin receptors. Brain Res Bull 2000; 51: 425-31.
91. Segraves RT, Clayton A, Croft H, Wolf A, Warnock J. Bupropion sustained release for the treatment of hypoactive sexual desire disorder in premenopausal women. J Clin Psychopharmacol 2004; 24: 339-42.